BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36918899)

  • 1. The effect of a low renal acid load diet on blood pressure, lipid profile, and blood glucose indices in patients with type 2 diabetes: a randomized clinical trial.
    Armin M; Heidari Z; Askari G; Iraj B; Clark CCT; Rouhani MH
    Nutr J; 2023 Mar; 22(1):18. PubMed ID: 36918899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of concentrated beetroot juice consumption on glycemic control, blood pressure, and lipid profile in type 2 diabetes patients: randomized clinical trial study.
    Karimzadeh L; Sohrab G; Hedayati M; Ebrahimof S; Emami G; Razavion T
    Ir J Med Sci; 2023 Jun; 192(3):1143-1153. PubMed ID: 35869311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial.
    Samadi N; Mozaffari-Khosravi H; Rahmanian M; Askarishahi M
    J Integr Med; 2017 Mar; 15(2):124-134. PubMed ID: 28285617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
    Aghasi M; Koohdani F; Qorbani M; Nasli-Esfahani E; Ghazi-Zahedi S; Khoshamal H; Keshavarz A; Sotoudeh G
    J Sci Food Agric; 2019 Jun; 99(8):3933-3940. PubMed ID: 30701554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low fructose diet on glycemic control, lipid profile and systemic inflammation in patients with type 2 diabetes: A single-blind randomized controlled trial.
    Jalilvand A; Behrouz V; Nikpayam O; Sohrab G; Hekmatdoost A
    Diabetes Metab Syndr; 2020; 14(5):849-855. PubMed ID: 32559734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial.
    Werida RH; Ramzy A; Ebrahim YN; Helmy MW
    BMC Endocr Disord; 2023 Nov; 23(1):259. PubMed ID: 38001474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary acid load, blood pressure, fasting blood sugar and biomarkers of insulin resistance among adults: Findings from an updated systematic review and meta-analysis.
    Dehghan P; Abbasalizad Farhangi M
    Int J Clin Pract; 2020 Apr; 74(4):e13471. PubMed ID: 31884719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of rutin flavonoid supplement on glycemic status, lipid profile, atherogenic index of plasma, brain-derived neurotrophic factor (BDNF), some serum inflammatory, and oxidative stress factors in patients with type 2 diabetes mellitus: A double-blind, placebo-controlled trial.
    Bazyar H; Moradi L; Zaman F; Zare Javid A
    Phytother Res; 2023 Jan; 37(1):271-284. PubMed ID: 36101997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial.
    Roshan H; Nikpayam O; Sedaghat M; Sohrab G
    Br J Nutr; 2018 Feb; 119(3):250-258. PubMed ID: 29307310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
    Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
    J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
    Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial.
    Roncero-Ramos I; Gutierrez-Mariscal FM; Gomez-Delgado F; Villasanta-Gonzalez A; Torres-Peña JD; Cruz-Ares S; Rangel-Zuñiga OA; Luque RM; Ordovas JM; Delgado-Lista J; Perez-Martinez P; Camargo A; Alcalá-Diaz JF; Lopez-Miranda J
    Transl Res; 2021 Dec; 238():12-24. PubMed ID: 34298148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double blind placebo controlled clinical trial.
    Nabhani Z; Hezaveh SJG; Razmpoosh E; Asghari-Jafarabadi M; Gargari BP
    Diabetes Res Clin Pract; 2018 Apr; 138():149-157. PubMed ID: 29432772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of TRX Suspension Training Combined with Taurine Supplementation on Body Composition, Glycemic and Lipid Markers in Women with Type 2 Diabetes.
    Samadpour Masouleh S; Bagheri R; Ashtary-Larky D; Cheraghloo N; Wong A; Yousefi Bilesvar O; Suzuki K; Siahkouhian M
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of MK-7 Supplementation on Glycemic Status, Anthropometric Indices and Lipid Profile in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    Karamzad N; Faraji E; Adeli S; Carson-Chahhoud K; Azizi S; Pourghassem Gargari B
    Diabetes Metab Syndr Obes; 2020; 13():2239-2249. PubMed ID: 32617013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials.
    Chiavaroli L; Lee D; Ahmed A; Cheung A; Khan TA; Blanco S; Mejia ; Mirrahimi A; Jenkins DJA; Livesey G; Wolever TMS; Rahelić D; Kahleová H; Salas-Salvadó J; Kendall CWC; Sievenpiper JL
    BMJ; 2021 Aug; 374():n1651. PubMed ID: 34348965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
    Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of green coffee aqueous extract supplementation on glycemic indices, lipid profile, CRP, and malondialdehyde in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Khalili-Moghadam S; Hedayati M; Golzarand M; Mirmiran P
    Front Nutr; 2023; 10():1241844. PubMed ID: 38035358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Yu Z; Nan F; Wang LY; Jiang H; Chen W; Jiang Y
    Clin Nutr; 2020 Jun; 39(6):1724-1734. PubMed ID: 31466731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.